This work is licensed under the Creative Commons Attribution 4.0 International License.
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-63. doi: 10.3322/caac.21834BrayFLaversanneMSungHFerlayJSiegelRLSoerjomataramIGlobal cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin2024; 74: 229-63. 10.3322/caac.21834Open DOISearch in Google Scholar
World Health Organisation. Cervical cancer [Internet]. Geneva: World Health Organisation; 2024. [cited 2025 Jan 10]. Available at: https://www. who.int/news-room/fact-sheets/detail/cervical-cancerWorld Health Organisation. Cervical cancer [Internet]. Geneva: World Health Organisation; 2024. [cited 2025 Jan 10]. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancerSearch in Google Scholar
Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013; 105: 175-201. doi: 10.1093/jnci/djs491JemalASimardEPDorellCNooneAMMarkowitzLEKohlerBAnnual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst2013; 105: 175-201. 10.1093/jnci/djs491Open DOISearch in Google Scholar
de Sanjose S, Brotons M, LaMontagne DS, Bruni L. Human papillomavirus vaccine disease impact beyond expectations. Curr Opin Virol 2019; 39: 16-22. doi: 10.1016/j.coviro.2019.06.006de SanjoseSBrotonsMLaMontagneDSBruniL.Human papillomavirus vaccine disease impact beyond expectations. Curr Opin Virol2019; 39: 16-22. 10.1016/j.coviro.2019.06.006Open DOISearch in Google Scholar
WHO Classification of Tumours Editorial Board. Female genital tumours. 5th edition. Lyon: International Agency for Research on Cancer; 2020.WHO Classification of Tumours Editorial Board. Female genital tumours. 5th edition. Lyon: International Agency for Research on Cancer; 2020.Search in Google Scholar
Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, Luff RD, et al; Members of the LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 2013; 32: 76-115. doi: 10.1097/PGP.0b013e31826916c7. Erratum in: Int J Gynecol Pathol 2013; 32: 432. Erratum in: Int J Gynecol Pathol 2013; 32: 241.DarraghTMColganTJThomas CoxJHellerDSHenryMRLuffRDMembers of the LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol2013; 32: 76-115. 10.1097/PGP.0b013e31826916c7. Erratum in: Int J Gynecol Pathol 2013; 32: 432. Erratum in: Int J Gynecol Pathol 2013; 32: 241.Open DOISearch in Google Scholar
Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers 2016; 2: 16086. doi: 10.1038/nrdp.2016.86SchiffmanMDoorbarJWentzensenNde SanjoséSFakhryCMonkBJCarcinogenic human papillomavirus infection. Nat Rev Dis Primers2016; 2: 16086. 10.1038/nrdp.2016.86Open DOISearch in Google Scholar
Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-84. doi: 10.1002/ijc.1174KlaesRFriedrichTSpitkovskyDRidderRRudyWPetryUOverexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer2001; 92: 276-84. 10.1002/ijc.1174Open DOISearch in Google Scholar
Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cárdenas J, Hernándes, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ 2018; 360: k499. doi: 10.1136/bmj.k499TainioKAthanasiouATikkinenKAOAaltonenRCárdenasJHernándesClinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ2018; 360: k499. 10.1136/bmj.k499Open DOISearch in Google Scholar
Mccredie MRE, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Articles natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425-34. doi: 10.1016/S1470-2045(08)70103-7MccredieMRESharplesKJPaulCBaranyaiJMedleyGJonesRWArticles natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol2008; 9: 425-34. 10.1016/S1470-2045(08)70103-7Open DOISearch in Google Scholar
Mills AM, Paquette C, Castle PE, Stoler MH. Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trials. Am J Surg Pathol 2015; 39: 611-7. doi: 10.1097/PAS.0000000000000374MillsAMPaquetteCCastlePEStolerMH.Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trials. Am J Surg Pathol2015; 39: 611-7. 10.1097/PAS.0000000000000374Open DOISearch in Google Scholar
Sagasta A, Castillo P, Saco A, Torné A, Esteve R, Marimon L, et al. p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix. Mod Pathol 2016; 29: 51-9. doi: 10.1038/modpathol.2015.126SagastaACastilloPSacoATornéAEsteveRMarimonLp16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix. Mod Pathol2016; 29: 51-9. 10.1038/modpathol.2015.126Open DOISearch in Google Scholar
Barken SS, Rebolj M, Andersen ES, Lynge E. Frequency of cervical intraepithelial neoplasia treatment in a well-screened population. Int J Cancer 2012; 130: 2438-44. doi: 10.1002/ijc.26248BarkenSSReboljMAndersenESLyngeE.Frequency of cervical intraepithelial neoplasia treatment in a well-screened population. Int J Cancer2012; 130: 2438-44. 10.1002/ijc.26248Open DOISearch in Google Scholar
de Vicente JC, Rodríguez-Santamarta T, Rodrigo JP, Allonca E, Vallina A, Singhania A, et al. The emerging role of NANOG as an early cancer risk biomarker in patients with oral potentially malignant disorders. J Clin Med 2019; 8: 1376. doi: 10.3390/jcm8091376de VicenteJCRodríguez-SantamartaTRodrigoJPAlloncaEVallinaASinghaniaAThe emerging role of NANOG as an early cancer risk biomarker in patients with oral potentially malignant disorders. J Clin Med2019; 8: 1376. 10.3390/jcm8091376Open DOISearch in Google Scholar
Rodrigo JP, Villaronga MÁ, Menéndez ST, Hermida-Prado F, Quer M, Vilaseca I, et al. A novel role for NANOG as an early cancer risk marker in patients with laryngeal precancerous lesions. Sci Rep 2017; 7: 11110. doi: 10.1038/s41598-017-11709-9RodrigoJPVillarongaMÁMenéndezSTHermida-PradoFQuerMVilasecaIA novel role for NANOG as an early cancer risk marker in patients with laryngeal precancerous lesions. Sci Rep2017; 7: 11110. 10.1038/s41598-017-11709-9Open DOISearch in Google Scholar
Huang R, Rofstad EK. Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget 2017; 8: 35351-67. doi: 10.18632/oncotarget.10169HuangRRofstadEK.Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget2017; 8: 35351-67. 10.18632/oncotarget.10169Open DOISearch in Google Scholar
Takebe N, Percy Ivy S. Controversies in cancer stem cells: targeting embryonic signaling pathways. Clin Cancer Res 2010; 16: 3106-12. doi: 10.1158/1078-0432.CCR-09-2934TakebeNPercy IvyS.Controversies in cancer stem cells: targeting embryonic signaling pathways. Clin Cancer Res2010; 16: 3106-12. 10.1158/1078-0432.CCR-09-2934Open DOISearch in Google Scholar
Prado MM, Frampton AE, Stebbing J, Krell J. Gene of the month: NANOG. J Clin Pathol 2015; 68: 763-5. doi: 10.1136/jclinpath-2015-203238PradoMMFramptonAEStebbingJKrellJ.Gene of the month: NANOG. J Clin Pathol2015; 68: 763-5. 10.1136/jclinpath-2015-203238Open DOISearch in Google Scholar
Maier S, Wilbertz T, Braun M, Scheble V, Reischl M, Mikut R, et al. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Hum Pathol 2011; 42: 1078-88. doi: 10.1016/j.humpath.2010.11.010MaierSWilbertzTBraunMSchebleVReischlMMikutRSOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Hum Pathol2011; 42: 1078-88. 10.1016/j.humpath.2010.11.010Open DOISearch in Google Scholar
Porter L, McCaughan F. SOX2 and squamous cancers. Semin Cancer Biol 2020. 67: 154-67. doi: 10.1016/j.semcancer.2020.05.007PorterLMcCaughanF.SOX2 and squamous cancers. Semin Cancer Biol2020. 67: 154-67. 10.1016/j.semcancer.2020.05.007Open DOISearch in Google Scholar
Ji J, Wei X, Wang Y. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7: 2470-6. PMID: 24966958JiJWeiXWangY.Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma. Int J Clin Exp Pathol2014; 7: 2470-6. PMID: 24966958Search in Google Scholar
Xu R, Yang WT, Zheng PS. Coexpression of B-lymphoma Moloney murine leukemia virus insertion region-1 and sex-determining region of Y chromosome-related high mobility group box-2 in cervical carcinogenesis. Hum Pathol 2013; 44: 208-17. doi: 10.1016/j.humpath.2012.02.020XuRYangWTZhengPS.Coexpression of B-lymphoma Moloney murine leukemia virus insertion region-1 and sex-determining region of Y chromosome-related high mobility group box-2 in cervical carcinogenesis. Hum Pathol2013; 44: 208-17. 10.1016/j.humpath.2012.02.020Open DOISearch in Google Scholar
Ji J, Zheng PS. Expression of Sox2 in human cervical carcinogenesis. Hum Pathol 2010; 41: 1438-47. doi: 10.1016/j.humpath.2009.11.021JiJZhengPS.Expression of Sox2 in human cervical carcinogenesis. Hum Pathol2010; 41: 1438-47. 10.1016/j.humpath.2009.11.021Open DOISearch in Google Scholar
Yang Z, Pan X, Gao A, Zhu W. Expression of Sox2 in cervical squamous cell carcinoma. J BUON 2014; 19: 203-6. PMID: 24659665YangZPanXGaoAZhuW.Expression of Sox2 in cervical squamous cell carcinoma. J BUON2014; 19: 203-6. PMID: 24659665Search in Google Scholar
Shen L, Huang X, Xie X, Su J, Yuan J, Chen X. High Expression of SOX2 and OCT4 Indicates radiation resistance and an independent negative prognosis in cervical squamous cell carcinoma. J Histochem Cytochem 2014; 62: 499-509. doi: 10.1369/0022155414532654ShenLHuangXXieXSuJYuanJChenX.High Expression of SOX2 and OCT4 Indicates radiation resistance and an independent negative prognosis in cervical squamous cell carcinoma. J Histochem Cytochem2014; 62: 499-509. 10.1369/0022155414532654Open DOISearch in Google Scholar
Moshi JM, Hoogduin KJ, Ummelen M, Henfling MER, van Engeland M, Wouters KAD, et al. Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix. Cancer Med 2020; 9: 6330-43. doi: 10.1002/cam4.3201MoshiJMHoogduinKJUmmelenMHenflingMERvan EngelandMWoutersKADSwitches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix. Cancer Med2020; 9: 6330-43. 10.1002/cam4.3201Open DOISearch in Google Scholar
Hou T, Zhang W, Tong C, Kazobinka G, Huang X, Huang Y, et al. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome. BMC Cancer 2015 24; 15: 785. doi: 10.1186/s12885-015-1826-4HouTZhangWTongCKazobinkaGHuangXHuangYPutative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome. BMC Cancer2015 24; 15: 785. 10.1186/s12885-015-1826-4Open DOISearch in Google Scholar
Kim BW, Cho H, Choi CH, Ylaya K, Chung JY, Kim JH, et al. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer. BMC Cancer 2015; 15: 1015. doi: 10.1186/s12885-015-2015-1KimBWChoHChoiCHYlayaKChungJYKimJHClinical significance of OCT4 and SOX2 protein expression in cervical cancer. BMC Cancer2015; 15: 1015. 10.1186/s12885-015-2015-1Open DOISearch in Google Scholar
Wolsky RJ, Harbour LN, Mirza KM, Montag AG, Gwin K. The stem cell-associated transcription factor SOX2 as a diagnostic marker of high-grade squamous intraepithelial lesion of the uterine cervix in comparison with p16 and Ki-67. Appl Immunohistochem Mol Morphol 2018; 26: 403-10. doi: 10.1097/PAI.0000000000000434WolskyRJHarbourLNMirzaKMMontagAGGwinK.The stem cell-associated transcription factor SOX2 as a diagnostic marker of high-grade squamous intraepithelial lesion of the uterine cervix in comparison with p16 and Ki-67. Appl Immunohistochem Mol Morphol2018; 26: 403-10. 10.1097/PAI.0000000000000434Open DOISearch in Google Scholar
Stewart CJ, Crook M. SOX2 expression in cervical intraepithelial neoplasia Grade 3 (CIN3) and superficially invasive (Stage IA1) squamous carcinoma of the cervix. Int J Gynecol Pathol 2016; 35: 566-73. doi: 10.1097/PGP.0000000000000273StewartCJCrookM.SOX2 expression in cervical intraepithelial neoplasia Grade 3 (CIN3) and superficially invasive (Stage IA1) squamous carcinoma of the cervix. Int J Gynecol Pathol2016; 35: 566-73. 10.1097/PGP.0000000000000273Open DOISearch in Google Scholar
Atıgan A, Kılıç D, Karakaya YA, Gök S, Güler ÖT. The relationship of immunohistochemical SOX-2 staining with histopathological diagnosis in patients with abnormal colposcopic findings. Histochem Cell Biol 2023;1 60: 555-61. doi: 10.1007/s00418-023-02230-4AtıganAKılıçDKarakayaYAGökSGülerÖT.The relationship of immunohistochemical SOX-2 staining with histopathological diagnosis in patients with abnormal colposcopic findings. Histochem Cell Biol2023;160: 555-61. 10.1007/s00418-023-02230-4Open DOISearch in Google Scholar
Moshi JM, Ummelen M, Broers JLV, Smedts F, van de Vijver KK, Cleutjens JPM, et al. SOX2 expression in the pathogenesis of premalignant lesions of the uterine cervix: its histo-topographical distribution distinguishes between low-and high-grade CIN. Histochem Cell Biol 2022; 158: 545-59. doi: 10.1007/s00418-022-02145-6MoshiJMUmmelenMBroersJLVSmedtsFvan de VijverKKCleutjensJPMSOX2 expression in the pathogenesis of premalignant lesions of the uterine cervix: its histo-topographical distribution distinguishes between low-and high-grade CIN. Histochem Cell Biol2022; 158: 545-59. 10.1007/s00418-022-02145-6Open DOISearch in Google Scholar
Javed S, Sood S, Rai B, Bhattacharyya S, Bagga R, Srinivasan R. ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy. Indian J Med Res. 2021; 154: 367-74. doi: 10.4103/ijmr.IJMR_709_20JavedSSoodSRaiBBhattacharyyaSBaggaRSrinivasanR.ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy. Indian J Med Res. 2021; 154: 367-74. 10.4103/ijmr.IJMR_709_20Open DOISearch in Google Scholar
Gu TT, Liu SY, Zheng PS. Cytoplasmic NANOG-positive stromal cells promote human cervical cancer progression. Am J Pathol 2012; 181: 652-61. doi: 10.1016/j.ajpath.2012.04.008GuTTLiuSYZhengPS.Cytoplasmic NANOG-positive stromal cells promote human cervical cancer progression. Am J Pathol2012; 181: 652-61. 10.1016/j.ajpath.2012.04.008Open DOISearch in Google Scholar
Noh KH, Kim BW, Song KH, Cho H, Lee YH, Kim JH, et al. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest 2012; 122: 4077-93. doi: 10.1172/JCI64057NohKHKimBWSongKHChoHLeeYHKimJHNanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest2012; 122: 4077-93. 10.1172/JCI64057Open DOISearch in Google Scholar
Ye F, Zhou C, Cheng Q, Shen J, Chen H. Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 2008; 8: 108. doi: 10.1186/1471-2407-8-108YeFZhouCChengQShenJChenH.Stem-cell-abundant proteins Nanog Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer2008; 8: 108. 10.1186/1471-2407-8-108Open DOISearch in Google Scholar
Grubelnik G, Boštjančič E, Grošelj A, Zidar N. Expression of NANOG and its regulation in oral squamous cell carcinoma. Biomed Res Int 2020; 2020: 8573793. doi: 10.1155/2020/8573793GrubelnikGBoštjančičEGrošeljAZidarN.Expression of NANOG and its regulation in oral squamous cell carcinoma. Biomed Res Int2020; 2020: 8573793. 10.1155/2020/8573793Open DOISearch in Google Scholar
Lillsunde Larsson G, Carlsson J, Karlsson MG, Helenius G. Evaluation of HPV genotyping assays for archival clinical samples. J Mol Diagn 2015; 17: 293-301. doi: 10.1016/j.jmoldx.2014.12.004Lillsunde LarssonGCarlssonJKarlssonMGHeleniusG.Evaluation of HPV genotyping assays for archival clinical samples. J Mol Diagn2015; 17: 293-301. 10.1016/j.jmoldx.2014.12.004Open DOISearch in Google Scholar
Seegene Inc. Anyplex™ II HPV28 detection user manual. Seoul: Seegene Inc; 2016.Seegene Inc. Anyplex™ II HPV28 detection user manual. Seoul: Seegene Inc; 2016.Search in Google Scholar
van Zummeren M, Leeman A, Kremer WW, Bleeker MCG, Jenkins D, van de Sandt M, et al. Three-tiered score for Ki-67 and p16ink4a improves accuracy and reproducibility of grading CIN lesions. J Clin Pathol 2018; 71: 981-8. doi: 10.1136/jclinpath-2018-205271van ZummerenMLeemanAKremerWWBleekerMCGJenkinsDvan de SandtMThree-tiered score for Ki-67 and p16ink4a improves accuracy and reproducibility of grading CIN lesions. J Clin Pathol2018; 71: 981-8. 10.1136/jclinpath-2018-205271Open DOISearch in Google Scholar
Garland SM, Iftner T, Cuschieri K, Kaufmann AM, Arbyn M, de Sanjose S, et al; IPVS Policy Committee. IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: quality assurance and quality control issues. J Clin Virol 2023; 159: 105349. doi: 10.1016/j.jcv.2022.105349GarlandSMIftnerTCuschieriKKaufmannAMArbynMde SanjoseSIPVS Policy Committee. IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: quality assurance and quality control issues. J Clin Virol2023; 159: 105349. 10.1016/j.jcv.2022.105349Open DOISearch in Google Scholar
Vasefifar P, Motafakkerazad R, Maleki LA, Najafi S, Ghrobaninezhad F, Najafzadeh B, et al. Nanog, as a key cancer stem cell marker in tumor progression. Gene 2022; 827: 146448. doi: 10.1016/j.gene.2022.146448VasefifarPMotafakkerazadRMalekiLANajafiSGhrobaninezhadFNajafzadehBNanog, as a key cancer stem cell marker in tumor progression. Gene2022; 827: 146448. 10.1016/j.gene.2022.146448Open DOISearch in Google Scholar
Grubelnik G, Boštjančič E, Pavlič A, Kos M, Zidar N. NANOG expression in human development and cancerogenesis. Exp Biol Med (Maywood) 2020; 245: 456-64. doi: 10.1177/1535370220905560GrubelnikGBoštjančičEPavličAKosMZidarN.NANOG expression in human development and cancerogenesis. Exp Biol Med (Maywood)2020; 245: 456-64. 10.1177/1535370220905560Open DOISearch in Google Scholar
Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. Human papillomavirus and related diseases in the world. Summary report [Internet]. Barcelona: ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2023. [cited 2025 Feb 28]. Available from: https://hpvcentre.net/statistics/reports/XWX.pdfBruniLAlberoGSerranoBMenaMColladoJJGómezDHuman papillomavirus and related diseases in the world. Summary report [Internet]. Barcelona: ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2023. [cited 2025 Feb 28]. Available from: https://hpvcentre.net/statistics/reports/XWX.pdfSearch in Google Scholar
Chaturvedi AK, Katki HA, Hildesheim A, Rodríguez AC, Quint W, Schiffman M, et al; CVT Group. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011;203: 910-20. doi: 10.1093/infdis/jiq139ChaturvediAKKatkiHAHildesheimARodríguezACQuintWSchiffmanMCVT GroupHuman papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis2011;203: 910-20. 10.1093/infdis/jiq139Open DOISearch in Google Scholar
Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007; 7: 11-22. doi: 10.1038/nrc2050WoodmanCBCollinsSIYoungLS.The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer2007; 7: 11-22. 10.1038/nrc2050Open DOISearch in Google Scholar
Organista-Nava J, Gómez-Gómez Y, Ocadiz-Delgado R, García-Villa E, Bonilla-Delgado J, Lagunas-Martínez A, et al. The HPV16 E7 oncoprotein increases the expression of Oct3/4 and stemness-related genes and augments cell self-renewal. Virology 2016; 499: 230-42. doi: 10.1016/j.virol.2016.09.020Organista-NavaJGómez-GómezYOcadiz-DelgadoRGarcía-VillaEBonilla-DelgadoJLagunas-MartínezAThe HPV16 E7 oncoprotein increases the expression of Oct3/4 and stemness-related genes and augments cell self-renewal. Virology2016; 499: 230-42. 10.1016/j.virol.2016.09.020Open DOISearch in Google Scholar
Kareta MS, Gorges LL, Hafeez S, Benayoun BA, Marro S, Zmoos AF, et al. Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis. Cell Stem Cell 2015; 16: 39-50. doi: 10.1016/j.stem.2014.10.019KaretaMSGorgesLLHafeezSBenayounBAMarroSZmoosAFInhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis. Cell Stem Cell2015; 16: 39-50. 10.1016/j.stem.2014.10.019Open DOISearch in Google Scholar
Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005; 7: 165-71. doi: 10.1038/ncb1211LinTChaoCSaitoSMazurSJMurphyMEAppellaEp53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol2005; 7: 165-71. 10.1038/ncb1211Open DOISearch in Google Scholar
Tyagi A, Vishnoi K, Mahata S, Verma G, Srivastava Y, Masaldan S, et al. Cervical cancer stem cells selectively overexpress HPV oncoprotein E6 that controls stemness and self-renewal through upregulation of HES1. Clin Cancer Res 2016; 22: 4170-84. doi: 10.1158/1078-0432.CCR-15-2574TyagiAVishnoiKMahataSVermaGSrivastavaYMasaldanSCervical cancer stem cells selectively overexpress HPV oncoprotein E6 that controls stemness and self-renewal through upregulation of HES1. Clin Cancer Res2016; 22: 4170-84. 10.1158/1078-0432.CCR-15-2574Open DOISearch in Google Scholar
Xi R, Pan S, Chen X, Hui B, Zhang L, Fu S, et al. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo. Oncotarget 2016; 7: 57050-65. doi: 10.18632/oncotarget.10959XiRPanSChenXHuiBZhangLFuSHPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo. Oncotarget2016; 7: 57050-65. 10.18632/oncotarget.10959Open DOISearch in Google Scholar
Martínez-Ramírez I, del-Castillo-Falconi V, Mitre-Aguilar IB, Amador-Molina A, Carrillo-García A, Langley E, et al. SOX2 as a new regulator of HPV16 transcription. Viruses 2017; 9: 175. doi: 10.3390/v9070175Martínez-RamírezIdel-Castillo-FalconiVMitre-AguilarIBAmador-MolinaACarrillo-GarcíaALangleyESOX2 as a new regulator of HPV16 transcription. Viruses2017; 9: 175. 10.3390/v9070175Open DOISearch in Google Scholar
Díaz-Tejeda Y, Guido-Jiménez MC, López-Carbajal H, Amador-Molina A, Méndez-Martínez R, Gariglio-Vidal P, et al. Nanog, in cooperation with AP1, increases the expression of E6/E7 oncogenes from HPV types 16/18. Viruses 2021; 13: 1482. doi: 10.3390/v13081482Díaz-TejedaYGuido-JiménezMCLópez-CarbajalHAmador-MolinaAMéndez-MartínezRGariglio-VidalPNanog, in cooperation with AP1, increases the expression of E6/E7 oncogenes from HPV types 16/18. Viruses2021; 13: 1482. 10.3390/v13081482Open DOISearch in Google Scholar
Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LHJ, Pauchnik M, et al. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 2005; 104: 2092-8. doi: 10.1002/cncr.21435HartAHHartleyLParkerKIbrahimMLooijengaLHJPauchnikMThe pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer2005; 104: 2092-8. 10.1002/cncr.21435Open DOISearch in Google Scholar
Chang DF, Tsai SC, Wang XC, Xia P, Senadheera D, Lutzko C. Molecular characterization of the human NANOG protein. Stem Cells 2009; 27: 812-21. doi: 10.1634/stemcells.2008-0657ChangDFTsaiSCWangXCXiaPSenadheeraDLutzkoC.Molecular characterization of the human NANOG protein. Stem Cells2009; 27: 812-21. 10.1634/stemcells.2008-0657Open DOISearch in Google Scholar
Mikulenkova E, Neradil J, Vymazal O, Skoda J, Veselska R. NANOG/NANOGP8 localizes at the centrosome and is spatiotemporally associated with centriole maturation. Cells 2020; 9: 692. doi: 10.3390/cells9030692MikulenkovaENeradilJVymazalOSkodaJVeselskaR.NANOG/NANOGP8 localizes at the centrosome and is spatiotemporally associated with centriole maturation. Cells2020; 9: 692. 10.3390/cells9030692Open DOISearch in Google Scholar
Driessens G, Blanpain C. Long live sox2: sox2 lasts a lifetime. Cell Stem Cell 2011; 9: 283-4. doi: 10.1016/j.stem.2011.09.007DriessensGBlanpainC.Long live sox2: sox2 lasts a lifetime. Cell Stem Cell2011; 9: 283-4. 10.1016/j.stem.2011.09.007Open DOISearch in Google Scholar
Mills AM, Coppock JD, Willis BC, Stoler MH. HPV E6/E7 mRNA in situ hybridization in the diagnosis of cervical low-grade squamous intraepithelial lesions (LSIL). Am J Surg Pathol 2018; 42: 192-200. doi: 10.1097/PAS.0000000000000974MillsAMCoppockJDWillisBCStolerMH.HPV E6/E7 mRNA in situ hybridization in the diagnosis of cervical low-grade squamous intraepithelial lesions (LSIL). Am J Surg Pathol2018; 42: 192-200. 10.1097/PAS.0000000000000974Open DOISearch in Google Scholar
Massad LS, Jeronimo J, Katki HA, Schiffman M; National Institutes of Health/American Society for Colposcopy and Cervical Pathology Research Group. The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis 2009; 13: 137-44. doi: 10.1097/LGT.0b013e31819308d4MassadLSJeronimoJKatkiHASchiffmanMNational Institutes of Health/American Society for Colposcopy and Cervical Pathology Research GroupThe accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis2009; 13: 137-44. 10.1097/LGT.0b013e31819308d4Open DOISearch in Google Scholar